Bial Pharmaceuticals

Industry

  • Pharmaceuticals
    • Generic Drugs
    • Vaccines
  • Biotechnology

Other Names/Subsidiaries

  • Bial – Portela & C.ª S.A., BIAL - R&D Investments S.A.
  • Societá Antichi Ritrovati Medical
  • Lysosomal Therapeutics
See more in Biomedtracker

Latest on Bial Pharmaceuticals

Pink Sheet

EU Crunch Time For 15 New Drugs At Final CHMP Meeting Of 2021

 
• By Neena Brizmohun

The European Medicines Agency is this week set to decide whether to recommend pan-EU marketing approval for 15 new drugs, including Xevudy (sotrovimab), Vir Biotechnology / GlaxoSmithKline ’s COVID-19

Scrip

Deal Watch: Lilly Teams Up With Lycia In Protein Degradation

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Pays $35m Up Front To Access Lyci

Scrip

SK’s Antiepileptic Speeds Japan Entry Via $500m Ono Partnership

 
• By Jung Won Shin

South Korea's SK Biopharmaceuticals Co., Ltd has reached another major licensing deal for cenobamate, this time with Ono Pharmaceutical Company, Ltd. for the exclusive development and commercializ

Scrip

Deal Watch: Private Equity-Backed Covis Bids To Buy Troubled AMAG

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Following Divestments, AMAG Fetches Net